GMT Capital’s Cogentix Medical, Inc. CGNT Stock Holding History

GMT Capital’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-21,304	Closed	-$67K	–	138
2017 Q4	$67K	Hold	21,304	–	–	﹤0.01%	124
2017 Q3	$55K	Buy	+21,304	New	+$46.7K	﹤0.01%	141
2017 Q2	–	Sell	-21,304	Closed	-$38K	–	122
2017 Q1	$38K	Sell	21,304 -56	-0.3%	-$111	﹤0.01%	121
2016 Q4	$43K	Hold	21,360	–	–	﹤0.01%	132
2016 Q3	$39K	Sell	21,360 -500	-2%	-$647	﹤0.01%	142
2016 Q2	$21K	Buy	21,860 +6,500	+42%	+$6.41K	﹤0.01%	139
2016 Q1	$17K	Hold	15,360	–	–	﹤0.01%	117
2015 Q4	$20K	Hold	15,360	–	–	﹤0.01%	105
2015 Q3	$24K	Hold	15,360	–	–	﹤0.01%	130
2015 Q2	$25K	Buy	+15,360	New	+$25.1K	﹤0.01%	117

Other funds holding CGNT

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GMT Capital's CGNT Position: Q1 2018 in Review

GMT Capital sold out of Cogentix Medical, Inc. (CGNT) in Q1 2018, closing a stake of 21,304 shares — an estimated $67K sold.

GMT Capital first reported a position in CGNT in Q2 2015 and held it in 10 quarters. The position peaked at $67K in Q4 2017. 47 funds tracked by Wall St. Rank hold CGNT as of Q1 2018.

GMT Capital reported no remaining Cogentix Medical, Inc. position as of Q1 2018 after selling out during the quarter.
GMT Capital sold 21,304 Cogentix Medical, Inc. shares in Q1 2018, an estimated $67K.
GMT Capital first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 10 quarters.
GMT Capital's Cogentix Medical, Inc. position peaked at $67K in Q4 2017.
47 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q1 2018.

Based on GMT Capital's 13F filing for Q1 2018, filed 15 May 2018.